Vancouver, Canada, April 09, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) (œClearmind or the œcompany), a clinical-stage biotech company focused on discovery and...
Vancouver, Canada, March 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) (Clearmind or the company), a biotech company focused on discovery and...
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:...
Clearmind Medicine Received Approval for Voluntary Delisting of Common Shares
Clearmind Medicine Obtains Clearance for its Alcoholism Clinical Trial